zm 241385 has been researched along with cardiovascular agents in 1 studies
| Studies (zm 241385) | Trials (zm 241385) | Recent Studies (post-2010) (zm 241385) | Studies (cardiovascular agents) | Trials (cardiovascular agents) | Recent Studies (post-2010) (cardiovascular agents) |
|---|---|---|---|---|---|
| 401 | 3 | 124 | 17,645 | 1,480 | 6,891 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brooks, R; Collis, MG; Keddie, JR; Poucher, SM; Shaw, GR | 1 |
1 other study(ies) available for zm 241385 and cardiovascular agents
| Article | Year |
|---|---|
In vivo characterisation of ZM 241385, a selective adenosine A2A receptor antagonist.
Topics: Adenosine; Animals; Cardiovascular Agents; Decerebrate State; Dogs; Female; Heart Rate; Hindlimb; In Vitro Techniques; Myocardial Contraction; Purinergic P1 Receptor Antagonists; Rats; Rats, Inbred SHR; Regional Blood Flow; Triazines; Triazoles; Vasodilation | 1996 |